World's Best Scientists 2026 revealed!
Pertti J. Neuvonen

Pertti J. Neuvonen

D-Index & Metrics

Medicine

D-Index
115
Citations
44090
World Ranking
4590
National Ranking
52

Pertti J. Neuvonen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pertti J. Neuvonen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 541 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pertti J. Neuvonen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pertti J. Neuvonen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pertti J. Neuvonen was affiliated with the University of Helsinki in Finland. Their research contributions spanned several areas within medicine and health professions, focusing particularly on microbiology, physiology, genetics, and periodontics.

Their work addressed a range of topics including:

  • Gut microbiota and health
  • Salivary gland disorders and functions
  • Oral microbiology and periodontitis research
  • Chronic lymphocytic leukemia research
  • Immunodeficiency and autoimmune disorders
  • Lymphoma diagnosis and treatment
  • Child and adolescent health

Neuvonen's main fields of study were medicine and health professions, with subfields covering general health professions, molecular biology, physiology, periodontics, and genetics.

Their recent scholarly articles illustrated diverse research interests. Notable publications included:

  • "Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition," published in 2020 in Microbiome
  • "Posaconazole-ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment," published in 2023 in British Journal of Clinical Pharmacology
  • "Lifetime antimicrobial use is associated with weight status in early adolescence-A register-based cohort study," published in 2020 in Pediatric Obesity

Their research collaborations included frequent co-authorship with colleagues such as Heli Viljakainen, Rejane Augusta de Oliveira Figueiredo, Elisabete Weiderpass, Trine B. Rounge, and Sajan C. Raju.

Neuvonen published in prominent venues reflecting a multidisciplinary approach, including Microbiome, British Journal of Clinical Pharmacology, and Pediatric Obesity.

Best Publications

  • Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

    Pertti J. Neuvonen;Mikko Niemi;Janne T. Backman

  • Pharmacokinetic interactions with rifampicin : clinical relevance.

    Mikko Niemi;Janne T. Backman;Martin F. Fromm;Pertti J. Neuvonen

  • Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake

    Mikko Niemi;Marja K. Pasanen;Pertti J. Neuvonen

  • Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole

    Pertti J. Neuvonen;Teemu Kantola;Kari T. Kivistö

  • SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.

    Marja K. Pasanen;Mikko Neuvonen;Pertti J. Neuvonen;Mikko Niemi

  • High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

    Mikko Niemi;Elke Schaeffeler;Thomas Lang;Martin F Fromm

  • Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

    Marja K Pasanen;Hanna Fredrikson;Pertti J Neuvonen;Mikko Niemi

  • Midazolam Should Be Avoided in Patients Receiving the Systemic Antimycotics Ketoconazole or Itraconazole

    K. T. Olkkola;J. T. Backman;P. J. Neuvonen

  • ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

    Jenni Keskitalo;O Zolk;Martin F Fromm;Kaisa Kurkinen

  • Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.

    Mikko Niemi;Mikko Niemi;Mikko Niemi;Janne T. Backman;Janne T. Backman;Janne T. Backman;Lauri I. Kajosaari;Lauri I. Kajosaari;Lauri I. Kajosaari;Julian B. Leathart;Julian B. Leathart;Julian B. Leathart

  • Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.

    Jari J. Lilja;Kari T. Kivistö;Pertti J. Neuvonen

  • Effect of itraconazole on the pharmacokinetics of atorvastatin

    Teemu Kantola;Kari T. Kivistö;Pertti J. Neuvonen

  • Gemfibrozil greatly increases plasma concentrations of cerivastatin.

    Janne T. Backman;Carl Kyrklund;Mikko Neuvonen;Pertti J. Neuvonen

  • Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.

    Teemu Kantola;Kari T. Kivistö;Pertti J. Neuvonen

  • A potentially hazardous interaction between erythromycin and midazolam

    Klaus T Olkkola;Klaus T Olkkola;Klaus T Olkkola;Kari Aranko;Kari Aranko;Kari Aranko;Harri Luurila;Harri Luurila;Harri Luurila;Arja Hiller;Arja Hiller;Arja Hiller

  • Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

    Teemu Kantola;Kari T. Kivistö;Pertti J. Neuvonen

  • Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

    M. Niemi;J. T. Backman;M. Neuvonen;P. J. Neuvonen

  • Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

    Pertti J. Neuvonen;Kirsi-Maija Jalava

  • Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.

    Jari J. Lilja;Kari T. Kivistö;Pertti J. Neuvonen

  • Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

    Anu Varhe;Klaus T Olkkola;Pertti J Neuvonen

Frequent Co-Authors

Janne T. Backman
Janne T. Backman University of Helsinki
Mikko Niemi
Mikko Niemi University of Helsinki
Klaus T. Olkkola
Klaus T. Olkkola University of Helsinki
Mika Scheinin
Mika Scheinin Turku University Hospital
Michel Eichelbaum
Michel Eichelbaum University of Tübingen
Matthias Schwab
Matthias Schwab University of Tübingen
Eija Kalso
Eija Kalso University of Helsinki
Ann K. Daly
Ann K. Daly Newcastle University
Markku Partinen
Markku Partinen University of Helsinki
Elisabete Weiderpass
Elisabete Weiderpass International Agency For Research On Cancer

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online programs in healthcare can provide flexible, affordable pathways toward rewarding medical careers. Many students start their journey in health fields with a bachelors in health administration, gaining foundational knowledge in healthcare systems, policy, and management. This degree can lead directly to entry-level roles or be a stepping stone to advanced studies.

For those seeking leadership roles, pursuing one of the most affordable mha programs online offers specialized training in healthcare operations and administration. These online programs often allow students to continue working while furthering their education.

Clinical professionals might look to advance their practice through online pmhnp programs to become Psychiatric Mental Health Nurse Practitioners. These programs focus on mental health assessment, diagnosis, and treatment in diverse patient populations.

For nurses seeking the highest level of clinical education, there are many most affordable dnp programs available online. Earning a Doctor of Nursing Practice can open doors to leadership roles, advanced practice, and healthcare innovation.

Best Scientists Citing Pertti J. Neuvonen

Recently Published Articles